AstraZeneca in cancer deal with Daiichi Sankyo
Shares in drug maker Daiichi Sankyo soared after AstraZeneca agreed to pay the Japanese company up to $6.9 billion as part of an agreement to develop and market a potentially "transformative" cancer treatment.
via FOX BUSINESS NEWS https://ift.tt/2TJLP1Q
No comments:
Post a Comment